India Supreme Court Scores Drug Makers, Government Over Clinical Trials
This article was originally published in PharmAsia News
India's Supreme Court took the pharmaceutical industry and the government to task for what it called treatment of human beings as "guinea pigs" in testing drugs in clinical trials, many of which allegedly have been conducted illegally.
You may also be interested in...
Biocon Biologics upbeat on Lantus follow-on’s long revenue stream and prospects for interchangeability, while operational challenges resulted in some supply constraints during the fiscal second quarter.
Join us for a quick audio roundup of major developments in the international biopharma industry over the past week, as covered by Scrip's global team.
For the first time, the US FDA granted an emergency use authorization to a device that allows for the home collection of saliva for COVID-19 diagnosis. See what Scott Rabuka, senior director of molecular products at DNA Genotek, which developed the test, said about it here.